• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期胃癌根据组织学类型与脂肪组织体积呈现出不同的关联。

Early gastric cancer shows different associations with adipose tissue volume depending on histological type.

作者信息

Otani Kensuke, Kitayama Joji, Kaisaki Shoichi, Ishigami Hironori, Hidemura Akio, Fujishiro Mitsuhiro, Omata Masao, Nagawa Hirokazu

机构信息

Department of Surgical Oncology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

Gastric Cancer. 2008;11(2):86-95. doi: 10.1007/s10120-008-0459-6. Epub 2008 Jul 2.

DOI:10.1007/s10120-008-0459-6
PMID:18595015
Abstract

BACKGROUND

Visceral obesity is known to be a risk factor for diabetes and cardiovascular disease. Cancer of the gastric cardia has been shown to have a close association with obesity in Western countries. In order to examine the possible relationship between fat volume and the development of gastric cancer (GC), we quantified visceral and subcutaneous fat areas of computed tomography (CT) images of patients with early GC.

METHODS

A total of 210 patients who underwent endoscopic resection or surgical gastrectomy and whose disease was pathologically diagnosed as early GC were investigated for total fat area (TFA), visceral fat area (VFA), and subcutaneous fat area (SFA) with Fat Scan software, using a CT slice at the umbilical level, and the relationships of these findings with clinical and pathological data were analyzed. The same analysis was performed in 147 patients with early colorectal cancer (CRC).

RESULTS

TFA, VFA, and SFA values in GC patients were not significantly different from the values in CRC patients. These values did not differ with the location of the GC. However, patients with undifferentiated-type GC had significantly smaller VFAs and SFAs than those with differentiated-type GC. Among the patients with undifferentiated GC, TFA and SFA values in the patients with submucosal cancer were significantly smaller than those in the patients with mucosal cancer.

CONCLUSION

GC has different associations with adipose tissue volume according to its histological type. As compared with differentiated GC, lower adipose tissue volume may be a preferential environment for the development and progression of undifferentiated GC.

摘要

背景

内脏肥胖是已知的糖尿病和心血管疾病的危险因素。在西方国家,贲门癌已被证明与肥胖密切相关。为了研究脂肪体积与胃癌(GC)发生之间的可能关系,我们对早期GC患者的计算机断层扫描(CT)图像中的内脏和皮下脂肪面积进行了量化。

方法

使用Fat Scan软件,利用脐水平的CT切片,对210例行内镜切除或手术胃切除术且病理诊断为早期GC的患者进行总脂肪面积(TFA)、内脏脂肪面积(VFA)和皮下脂肪面积(SFA)的调查,并分析这些结果与临床和病理数据的关系。对147例早期结直肠癌(CRC)患者进行了同样的分析。

结果

GC患者的TFA、VFA和SFA值与CRC患者的值无显著差异。这些值与GC的位置无关。然而,未分化型GC患者的VFA和SFA明显小于分化型GC患者。在未分化GC患者中,黏膜下癌患者的TFA和SFA值明显小于黏膜癌患者。

结论

GC根据其组织学类型与脂肪组织体积有不同的关联。与分化型GC相比,较低的脂肪组织体积可能是未分化型GC发生和进展的有利环境。

相似文献

1
Early gastric cancer shows different associations with adipose tissue volume depending on histological type.早期胃癌根据组织学类型与脂肪组织体积呈现出不同的关联。
Gastric Cancer. 2008;11(2):86-95. doi: 10.1007/s10120-008-0459-6. Epub 2008 Jul 2.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.基于CT的结直肠癌患者脂肪组织与身体指标的分区定量分析
Eur Radiol. 2016 Nov;26(11):4131-4140. doi: 10.1007/s00330-016-4231-8. Epub 2016 Feb 6.
4
Vagus nerve preservation selectively restores visceral fat volume in patients with early gastric cancer who underwent gastrectomy.迷走神经保护选择性恢复行胃切除术的早期胃癌患者内脏脂肪量。
J Surg Res. 2012 Mar;173(1):60-7. doi: 10.1016/j.jss.2010.08.040. Epub 2010 Sep 22.
5
Differential Impact of Subcutaneous and Visceral Fat on Bone Changes after Gastrectomy.胃切除术后皮下和内脏脂肪对骨骼变化的影响差异。
Endocrinol Metab (Seoul). 2024 Aug;39(4):632-640. doi: 10.3803/EnM.2024.1956. Epub 2024 Jul 17.
6
Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study.新辅助治疗期间明显的脂肪组织丢失可作为预测胃癌患者预后不良的指标:一项回顾性队列研究。
J Hum Nutr Diet. 2021 Jun;34(3):585-594. doi: 10.1111/jhn.12861. Epub 2021 Jan 25.
7
Validating quantitative obesity measurements in colorectal cancer patients.验证结直肠癌患者的肥胖定量测量。
J Surg Res. 2010 Nov;164(1):18-22. doi: 10.1016/j.jss.2010.05.048. Epub 2010 Jun 13.
8
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.胃切除术后明显的肌肉、内脏脂肪或皮下脂肪丢失预测晚期胃癌的不良生存:来自 CLASSIC 试验的单中心研究。
Ann Surg Oncol. 2018 Oct;25(11):3222-3230. doi: 10.1245/s10434-018-6624-1. Epub 2018 Jul 26.
9
Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study.体质组成、肌肉力量和身体机能对胃癌根治术后并发症和生存的影响:一项大规模前瞻性研究的综合分析。
Clin Nutr. 2021 May;40(5):3360-3369. doi: 10.1016/j.clnu.2020.11.007. Epub 2020 Nov 11.
10
Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening.在接受一般健康筛查的无症状受试者中,皮下脂肪堆积增加对亚临床动脉粥样硬化具有保护作用。
Int J Cardiol. 2009 Jun 26;135(2):150-5. doi: 10.1016/j.ijcard.2008.03.044. Epub 2008 Jul 1.

引用本文的文献

1
Prognostic Value of Pretreatment Overweight/Obesity and Adipose Tissue Distribution in Resectable Gastric Cancer: A Retrospective Cohort Study.可切除胃癌患者术前超重/肥胖及脂肪组织分布的预后价值:一项回顾性队列研究
Front Oncol. 2021 Jun 24;11:680190. doi: 10.3389/fonc.2021.680190. eCollection 2021.
2
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.二甲双胍可限制脂肪细胞对卵巢癌的促肿瘤作用。
Oncotarget. 2014 Jul 15;5(13):4746-64. doi: 10.18632/oncotarget.2012.
3
Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.

本文引用的文献

1
Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.人脂联素抑制人子宫内膜癌细胞HEC-1-A和RL95 2的细胞生长并诱导其凋亡。
Endocr Relat Cancer. 2007 Sep;14(3):713-20. doi: 10.1677/ERC-07-0065.
2
Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets.代谢综合征与脂肪组织:新的临床观点及治疗靶点
Curr Pharm Des. 2007;13(21):2148-68. doi: 10.2174/138161207781039571.
3
Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan.
老年患者或近端肿瘤患者在早期胃癌中受益于代谢综合征。
PLoS One. 2014 Mar 5;9(3):e89965. doi: 10.1371/journal.pone.0089965. eCollection 2014.
4
Decreased body fat and gastric cancer: does the hen come before the egg, or vice versa?
Gastric Cancer. 2008;11(2):67-8. doi: 10.1007/s10120-008-0471-x.
日本代谢综合征患者的内脏肥胖:通过CT扫描对诊断标准的重新评估。
Hypertens Res. 2007 Apr;30(4):315-23. doi: 10.1291/hypres.30.315.
4
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2.脂联素通过其特异性膜受体AdipoR1和AdipoR2抑制胃癌的生长和腹膜转移。
Cancer Sci. 2007 Jul;98(7):1120-7. doi: 10.1111/j.1349-7006.2007.00486.x. Epub 2007 Apr 23.
5
Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.疾病机制:脂肪因子与乳腺癌——连接肥胖与乳腺癌的内分泌和旁分泌机制。
Nat Clin Pract Endocrinol Metab. 2007 Apr;3(4):345-54. doi: 10.1038/ncpendmet0456.
6
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.体重指数与食管或贲门腺癌:一项系统评价和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8. doi: 10.1158/1055-9965.EPI-05-0860.
7
Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells.脂联素介导人MCF7乳腺癌细胞的抗增殖和凋亡反应。
Biochem Biophys Res Commun. 2006 Jun 23;345(1):271-9. doi: 10.1016/j.bbrc.2006.04.076. Epub 2006 Apr 27.
8
Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.抑癌基因和肿瘤相关基因在胃癌发生发展过程中的改变。
World J Gastroenterol. 2006 Jan 14;12(2):192-8. doi: 10.3748/wjg.v12.i2.192.
9
Adiponectin as a growth inhibitor in prostate cancer cells.脂联素作为前列腺癌细胞中的生长抑制剂。
Biochem Biophys Res Commun. 2006 Feb 24;340(4):1158-66. doi: 10.1016/j.bbrc.2005.12.103. Epub 2005 Dec 27.
10
Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell.脂联素诱导MDA-MB-231乳腺癌细胞生长停滞和凋亡。
Arch Pharm Res. 2005 Nov;28(11):1263-9. doi: 10.1007/BF02978210.